Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | DUSP3 | P51452 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | DGKA | P23743 | 1/20 | 0.82 |
| ▸ | MAPT | P10636 | 1/20 | 0.69 |
| ▸ | FAAH | O00519 | 2/20 | 0.68 |
| ▸ | PRKCA | P17252 | 3/20 | 0.66 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.66 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.66 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.66 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.65 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.65 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.65 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.65 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.65 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.65 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2119138 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Monoctanoin Component B SCHEMBL22366087 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL2508008 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL2326840 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL21685815 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL21685794 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Glyceryl Monostearate SCHEMBL4488 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Glyceryl Monostearate SCHEMBL2489632 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Glyceryl Monostearate SCHEMBL1653474 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL10937708 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025129333-A1 | LIPID NANOPARTICLES HAVING NON-POLAR LIPIDS FOR NUCLEIC ACID DELIVERY TO THE LIVER | NANOVATION THERAPEUTICS INC. (CA) | 2025-06-26 | — | — | WO | claimed |
| WO-2025129333-A1 | LIPID NANOPARTICLES HAVING NON-POLAR LIPIDS FOR NUCLEIC ACID DELIVERY TO THE LIVER | NANOVATION THERAPEUTICS INC. (CA) | 2025-06-26 | — | — | WO | disclosed |
| EP-4451879-A1 | METHODS FOR ISOLATING ANTIMICROBIAL MICROORGANISMS FROM AGRICULTURAL PRODUCTS AND USES THEREOF | Apeel Technology, Inc. (US) | 2024-10-30 | — | — | EP | disclosed |
| WO-2023122793-A1 | METHODS FOR ISOLATING ANTIMICROBIAL MICROORGANISMS FROM AGRICULTURAL PRODUCTS AND USES THEREOF | APEEL TECHNOLOGY, INC. (US) | 2023-06-29 | — | — | WO | disclosed |
| EP-4114182-A1 | METHODS AND COMPOSITIONS FOR IMPROVING THE PROPERTIES AND PRODUCTIVITY OF PLANTS | Apeel Technology, Inc. (US) | 2023-01-11 | — | — | EP | disclosed |
| EP-4090167-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | Apeel Technology, Inc. (US) | 2022-11-23 | — | — | EP | disclosed |
| WO-2022217089-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECHNOLOGY, INC. (US) | 2022-10-13 | — | — | WO | disclosed |
| EP-3986149-A1 | COMPOUNDS EXTRACTED FROM PLANT MATTER AND METHODS OF PREPARATION THEREOF | Apeel Technology, Inc. (US) | 2022-04-27 | — | — | EP | disclosed |
| EP-3979805-A1 | METHOD OF PROTECTING ITEMS FROM DEGRADATION AND DECOMPOSITION | Apeel Technology, Inc. (US) | 2022-04-13 | — | — | EP | disclosed |
| EP-3846610-A1 | COMPOUNDS AND FORMULATIONS FOR PROTECTIVE COATINGS | Apeel Technology, Inc. (US) | 2021-07-14 | — | — | EP | disclosed |
| US-7906147-B2 | superparamagnetic nanoparticles of iron coated with bilayer of molecules:(a) layer of oleic acid in direct contact with the iron particles; (b) a layer of Tween\"; bilayer of surface binding molecules and amphiphatic molecules; self-assembles; solubilizing; reducing toxicity; gold in MRI and tomography | NANOPROBES, INC. (US) | 2011-03-15 | — | — | US | disclosed |
| US-7868196-B2 | Preparation of glycerol derivatives and intermediates therefor | ENZYCHEM CO., LTD. (KR) | 2011-01-11 | — | — | US | disclosed |
| EP-1907345-B1 | PREPARATION OF GLYCEROL DERIVATIVES AND INTERMEDIATES THEREFOR | ENZYCHEM CO LTD (KR) | 2009-10-21 | — | — | EP | disclosed |
| US-20090253923-A1 | Preparation of glycerol derivatives ad intermediates therefor | ENZYCHEM CO., LTD. | 2009-10-08 | — | — | US | disclosed |
| EP-1907345-A4 | PREPARATION OF GLYCEROL DERIVATIVES AND INTERMEDIATES THEREFOR | ENZYCHEM CO LTD (KR) | 2008-12-10 | — | — | EP | disclosed |
| CN-101223121-A | Preparation of glycerol derivatives and intermediates thereof | ENZYCHEM CO LTD (KR) | 2008-07-16 | — | — | CN | disclosed |
| US-7368603-B2 | Mixing compound with ion exchanger; controlling temperature; removal supernatant | LONZA LTD (CH) | 2008-05-06 | — | — | US | disclosed |
| EP-1907345-A1 | PREPARATION OF GLYCEROL DERIVATIVES AND INTERMEDIATES THEREFOR | Enzychem Co., Ltd. (KR) | 2008-04-09 | — | — | EP | disclosed |
| WO-2007011150-A1 | PREPARATION OF GLYCEROL DERIVATIVES AND INTERMEDIATES THEREFOR | ENZYCHEM CO., LTD. (KR) | 2007-01-25 | — | — | WO | disclosed |
| US-20040192967-A1 | Method for purifying compounds containing functional groups | LONZA LTD. (CH) | 2004-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090253923-A1 | Preparation of glycerol derivatives ad intermediates therefor | FAR1, GK, AGPAT2 | LMNA 2043/4885KDM4E 3757/4885DUSP3 3797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.